Learn more about how the innovation of chemically defined microbial media has created a new paradigm of microbial bioprocessing, one which has the potential to enhance the performance...
Over 70% of potential research participants live >2 hours away from sites, & patient drop-out rates can reach 30% depending on the therapeutic area. The Solution: eConsent Why...
Cell culture processes are complex and highly variable, and yet only a handful of key parameters are typically controlled in real time. Critical process parameters and key performance...
Drug manufacturers charged with developing, scaling up or scaling down any process involving crystallization face major challenges, given the industry's current understanding ...
Built-in ability to meet data integrity standards should be a central focus when selecting control systems and manufacturing execution systems for pharma manufacturing
Upholding rigorous quality standards is not only a regulatory imperative but also vital for ensuring the efficacy and safety of pharmaceutical products. And as many pharma manufacturers...
Nine out of 10 Fortune 500 executives surveyed expressed interest in the idea of outsourcing energy operations to reduce risk. Learn how an Energy as a Service model can support...
Discover how Blue Mountain's Regulatory Asset Manager (RAM) propelled AmplifyBio, a leading Contract Research Organization (CRO), into a paperless future.
mRNA-LNP manufacturing is fraught with obstacles, resulting in higher program risk, inflated costs, and delayed market release. With the right knowledge, companies can overcome...
During tableting processes, APIs become airborne. These dust particles can harm workers, reduce air quality, contaminate products and cause explosions. Learn how dust collectors...